RxDoctor Payments Data

Angela Martel, PA

Physician Assistant · Biddeford, MENPI 1174022453

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 28.0% of the total. Among physician assistant clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,650in general payments, 2019–2025

Across 81 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$463
  • Daiichi Sankyo Inc.$196
  • Lilly USA, LLC$184
  • Axsome Therapeutics, Inc.$139
  • GSK$117
  • AstraZeneca$109
  • plus $442 from 12 others

What the payments were for

  • Food & beverage$1,650100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,650 in reported general payments places this provider in the 95th percentile of 774 physician assistant providers in Maine.

See all physician assistant providers in Maine

Medicare billing

Part B allowed, 2024
$41,079
Medicare patients
181
Services billed
579

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide13$24,892
EliquisApixaban13$13,444
Bupropion XlBupropion Hcl18$665
Rosuvastatin Calcium16$576
Omeprazole31$436
Losartan Potassium32$368
Alendronate Sodium18$329
Levothyroxine Sodium29$295
Cephalexin11$291
Atorvastatin Calcium36$239
Amlodipine Besylate28$226
Sertraline Hcl22$223
Trazodone Hcl18$190
Gabapentin13$157
Metoprolol Succinate22$138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$33$24,89213 claims
PfizerEliquis$58$13,44413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 774 physician assistant providers in Maine.

Other physician assistant in Biddeford

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →